Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 19, Number 12—December 2013

New Delhi Metallo-β-Lactamase-1 in Carbapenem-Resistant Salmonella Strain, China

Cite This Article

To the Editor: Carbapenem resistance in Enterobacteriaceae can occur through the production of carbapenem-hydrolyzing enzymes such as New Delhi metallo-β-lactamase-1 (NDM-1) (1). In recent years, plasmid-mediated NDM-1 has spread rapidly worldwide and into multiple Enterobacteriaceae species, such as Klebsiella pneumoniae and Escherichia coli (2).

NDM-1 has been reported in 2 strains of Salmonella spp., which were isolated from feces and urine specimens during screening for multidrug-resistant bacteria in patients from India (3,4). We report the isolation of 1 community-acquired NDM-1–bearing Salmonella strain isolated from a child with acute diarrhea.

The Salmonella strain was isolated from the feces of an 11-month-old girl at Lishui Central Hospital, Zhejiang Province, China, on July 25, 2012. Six days before admission, a fever ≤40°C, accompanied by a cough, developed in the patient. Four days before admission, physical examination showed fine rales in both lungs. The leukocyte count was 8,900 cells/µL, with 80% neutrophils. No obvious abnormalities were found on a chest radiograph.

The patient was given a diagnosis of acute bronchitis, and the condition was treated with parenteral cefoxitin for 3 days and parenteral piperacillin/tazobactam for 1 day, but fever persisted. Two days before admission, diarrhea (4–5 times/day with loose feces containing mucus and blood) developed. On admission day, fecal analysis showed 3–4 leukocytes and 1–3 erythrocytes per high-power field. A Salmonella sp. was isolated from feces obtained at admission and identified as S. enterica subsp. enterica serovar Stanley by serotyping by the local Centers for Disease Control and Prevention.

The patient was then given a diagnosis of bacterial enteritis and received intravenous azithromycin and latamoxef. Fever and diarrhea resolved over the next 3 days. On the fifth day of hospitalization, a fecal culture was negative for Salmonella spp. and the patient was discharged. At a follow-up visit 3 months later, Salmonella spp. or other carbapenem-resistant bacteria were not isolated from feces samples from the patient or her grandmother and brother, who lived with her.

The patient and her family had not traveled to any country during the year, including countries with a high prevalence of NDM-1 producers. The patient was living in a small rural village in southern China and did not have a special diet. She was healthy before hospitalization for fever. She was born by cesarean section and did not have contacts with hospitalized patients.

MICs of antimicrobial drugs were determined by agar dilution and interpreted by using revised Clinical and Laboratory Standards Institute breakpoints (5). The Salmonella Stanley strain was resistant to all β-lactam antimicrobial drugs tested, including cephalosporins and carbapenems, but susceptible to chloramphenicol, ciprofloxacin, tetracycline, and fosfomycin, and had azithromycin MICs of 4 µg/mL (Table).

A modified Hodge test result for Salmonella strain Stanley was weakly positive. Production of metallo-β-lactamase was detected by using an imipenem-EDTA double-disk synergy test. Carbapenamase-encoding genes, including blaKPC-2, blaVIM, blaIMP, blaSPM-1, blaGIM-1, and blaSIM-1, were detected by using PCR as described (2). Only the blaNDM-1 gene was detected (with primers 5′-GGCGGAATGGCTCATCACGA-3′ and 5′-CGCAACACAGCCTGACTTTC-3′). The PCR product sequence was consistent with that of NDM-1 (GenBank accession no. FN396876).

Conjugation experiments were conducted as described (6). Carbapenem resistance could be transferred from Salmonella strain Stanley to E. coli C600 Rifr and K. pneumoniae 13883 Rifr at frequencies of 1 transconjugant per ≈1.0 × 104 and 4.0 × 107 bacterial cells, respectively, after exposure for 15 min.

Plasmid DNA was extracted by using a Plasmid Midi Kit (QIAGEN, Hilden, Germany) according to the manufacturer’s instructions. Electrophoresis showed that donor and transconjugant strains had the same plasmid profile; both contained an ≈140-kb plasmid. A PCR-based method for plasmid replicon typing (7) indicated that the plasmid belonged to incompatibility group IncA/C.

Experiments of blaNDM-1 stability in Salmonella spp., E. coli transconjugants, and K. pneumoniae transconjugants were conducted by using the method of Wang et al. (6). Twenty colonies were randomly selected every day during days 2–15. Only 2 colonies of the Salmonella Stanley strain lost carbapenem resistance; these colonies were collected on the second and ninth days of passage, respectively. Plasmids containing blaNDM-1were not present in these 2 colonies. No transconjugants lost carbapenem resistance during 14 days of passage.

Although Salmonella spp. have shown increased resistance to cephalosporins and quinolones, resistance to carbapenems is rare (3,4,8,9). Because of emerging resistance to traditionally recommended antimicrobial agents, azithromycin is increasingly used for treatment of invasive Salmonella spp. infections in children (10). The patient with carbapenem-resistant Salmonella infection and acute diarrhea was cured by treatment with azithromycin.

This report indicates ongoing spread of NDM-1–bearing Salmonella strains. If one considers the high conjugation frequency and stability of the IncA/C plasmid containing NDM-1 in Salmonella spp., one would conclude that it might increase spread of bacterial drug resistance. Prompt recognition of carbapenem-resistant Salmonella spp. and initiation of appropriate infection control measures are essential to avoid spread of these organisms.


Jinwei Huang1, Minghua Wang1, Hui Ding, Meiping Ye, Fupin Hu, Qinglan Guo, Xiaogang Xu, and Minggui WangComments to Author 
Author affiliations: Huashan Hospital, Fudan University, Shanghai, China (J. Huang, M. Wang, F. Hu, Q. Guo, X. Xu, M. Wang); Lishui Central Hospital, Lishui, China (J. Huang, H. Ding); and Wenzhou Medical University, Wenzhou, China (M. Ye)



  1. Yong  D, Toleman  MA, Giske  CG, Cho  HS, Sundman  K, Lee  K, Characterization of a new metallo-beta-lactamase gene, bla(NDM-1), and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India. Antimicrob Agents Chemother. 2009;53:504654. DOIPubMedGoogle Scholar
  2. Nordmann  P, Poirel  L, Walsh  TR, Livermore  DM. The emerging NDM carbapenemases. Trends Microbiol. 2011;19:58895. DOIPubMedGoogle Scholar
  3. Cabanes  F, Lemant  J, Picot  S, Simac  C, Cousty  J, Jalin  L, Emergence of Klebsiella pneumoniae and Salmonella metallo-beta-lactamase (NDM-1) producers on Reunion Island. J Clin Microbiol. 2012;50:3812. DOIPubMedGoogle Scholar
  4. Savard  P, Gopinath  R, Zhu  W, Kitchel  B, Rasheed  JK, Tekle  T, First NDM-positive Salmonella sp. strain identified in the United States. Antimicrob Agents Chemother. 2011;55:59578. DOIPubMedGoogle Scholar
  5. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. 22nd informational supplement. CLSI document M100–S22. Wayne (PA): The Institute; 2012.
  6. Wang  M, Tran  JH, Jacoby  GA, Zhang  Y, Wang  F, Hooper  DC. Plasmid-mediated quinolone resistance in clinical isolates of Escherichia coli from Shanghai, China. Antimicrob Agents Chemother. 2003;47:22428. DOIPubMedGoogle Scholar
  7. Johnson  TJ, Lang  KS. IncA/C plasmids: an emerging threat to human and animal health? Mob Genet Elements. 2012;2:55–8.
  8. Su  LH, Wu  TL, Chiu  CH. Development of carbapenem resistance during therapy for non-typhoid Salmonella infection. Clin Microbiol Infect. 2012;18:E914. DOIPubMedGoogle Scholar
  9. Cui  S, Li  J, Sun  Z, Hu  C, Jin  S, Guo  Y, Ciprofloxacin-resistant Salmonella enterica serotype Typhimurium, China. Emerg Infect Dis. 2008;14:4935. DOIPubMedGoogle Scholar
  10. Sjölund-Karlsson  M, Joyce  K, Blickenstaff  K, Ball  T, Haro  J, Medalla  FM, Antimicrobial susceptibility to azithromycin among Salmonella enterica isolates from the United States. Antimicrob Agents Chemother. 2011;55:39859. DOIPubMedGoogle Scholar




Cite This Article

DOI: 10.3201/eid1912.130051

1These authors contributed equally to this article.

Related Links


Table of Contents – Volume 19, Number 12—December 2013


Please use the form below to submit correspondence to the authors or contact them at the following address:

Minggui Wang, Institute of Antibiotics, Huashan Hospital, Fudan University, 12 M. Wulumuqi Rd, Shanghai 200040, People’s Republic of China,Minggui Wang, Institute of Antibiotics, Huashan Hospital, Fudan University, 12 M. Wulumuqi Rd, Shanghai 200040, People’s Republic of China,

Send To

10000 character(s) remaining.


Page created: November 20, 2013
Page updated: November 20, 2013
Page reviewed: November 20, 2013
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.